• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转铁蛋白功能化脂质纳米粒用于姜黄素脑递送。

Transferrin-functionalized lipid nanoparticles for curcumin brain delivery.

机构信息

LAQV, REQUIMTE, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, 4050-313, Porto, Portugal; CQM, Centro de Química da Madeira, Universidade da Madeira, Campus da Penteada, 9020-105 Funchal, Portugal.

LAQV, REQUIMTE, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, 4050-313, Porto, Portugal.

出版信息

J Biotechnol. 2021 Apr 10;331:108-117. doi: 10.1016/j.jbiotec.2021.03.010. Epub 2021 Mar 13.

DOI:10.1016/j.jbiotec.2021.03.010
PMID:33727082
Abstract

Curcumin is an anti-inflammatory and antioxidant compound with potent neuroprotective activity. Due to its poor water solubility, low bioavailability, rapid elimination and the challenges for crossing and transposing the blood-brain barrier (BBB), solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) loaded with curcumin were successfully produced and functionalized with transferrin, in order to mediate the transport of these particles through the BBB endothelium to the brain. The nanosystems revealed Z-averages under 200 nm, polydispersity index below 0.2 and zeta potential around -30 mV. Curcumin encapsulation around 65 % for SLNs and 80 % for NLCs was accomplished, while the functionalized nanoparticles presented a value around 70-75 %. A stability study revealed these characteristics remained unchanged for at least 3 months. hCMEC/D3 cells viability was firstly analysed by MTT and LDH assays, respectively, and a concentration of 10 μM of curcumin-loaded nanoparticles were then selected for the subsequent permeability assay. The permeability study was conducted using transwell devices with hCMEC/D3 cells monolayers and a 1.5-fold higher permeation of curcumin through the BBB was verified. Both SLNs and NLCs are promising for curcumin brain delivery, protecting the incorporated curcumin and targeting to the brain by the addition of transferrin to the nanoparticles surface.

摘要

姜黄素是一种具有抗炎和抗氧化活性的化合物,具有很强的神经保护作用。由于其水溶性差、生物利用度低、消除速度快以及穿越血脑屏障(BBB)的挑战,负载姜黄素的固体脂质纳米粒(SLNs)和纳米结构化脂质载体(NLCs)已成功制备并通过转铁蛋白功能化,以介导这些颗粒通过 BBB 内皮细胞向大脑的转运。纳米系统的 Z 均粒径小于 200nm,多分散指数低于 0.2,zeta 电位约为-30mV。实现了姜黄素包封率为 SLNs 约 65%和 NLCs 约 80%,而功能化纳米粒的包封率约为 70-75%。稳定性研究表明,这些特性至少在 3 个月内保持不变。首先通过 MTT 和 LDH 测定分析 hCMEC/D3 细胞活力,然后选择 10μM 载姜黄素纳米粒进行随后的渗透性测定。通过 hCMEC/D3 细胞单层的 Transwell 装置进行渗透性研究,证实姜黄素通过 BBB 的渗透增加了 1.5 倍。SLNs 和 NLCs 都可用于姜黄素的脑递送,通过在纳米粒表面添加转铁蛋白来保护所包含的姜黄素并靶向大脑。

相似文献

1
Transferrin-functionalized lipid nanoparticles for curcumin brain delivery.转铁蛋白功能化脂质纳米粒用于姜黄素脑递送。
J Biotechnol. 2021 Apr 10;331:108-117. doi: 10.1016/j.jbiotec.2021.03.010. Epub 2021 Mar 13.
2
Quercetin lipid nanoparticles functionalized with transferrin for Alzheimer's disease.转铁蛋白修饰的槲皮素脂质纳米粒用于阿尔茨海默病。
Eur J Pharm Sci. 2020 May 30;148:105314. doi: 10.1016/j.ejps.2020.105314. Epub 2020 Mar 19.
3
Brain-targeted delivery of resveratrol using solid lipid nanoparticles functionalized with apolipoprotein E.使用载脂蛋白E功能化的固体脂质纳米粒实现白藜芦醇的脑靶向递送。
J Nanobiotechnology. 2016 Apr 9;14:27. doi: 10.1186/s12951-016-0177-x.
4
In vivo Antiplasmodial Activity of Curcumin-Loaded Nanostructured Lipid Carriers.载姜黄素纳米结构脂质载体的体内抗疟活性。
Curr Drug Deliv. 2019;16(10):923-930. doi: 10.2174/1567201816666191029121036.
5
Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.液固脂质比对用于透皮给药的氟比洛芬固体脂质纳米粒(SLNs)和纳米结构脂质载体(NLCs)特性的影响。
Drug Dev Ind Pharm. 2016 Aug;42(8):1308-14. doi: 10.3109/03639045.2015.1132226. Epub 2016 Jan 20.
6
Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability.基于脂质纳米粒的新型白藜芦醇递药系统以提高其口服生物利用度。
Int J Nanomedicine. 2013;8:177-87. doi: 10.2147/IJN.S37840. Epub 2013 Jan 7.
7
RVG29-Functionalized Lipid Nanoparticles for Quercetin Brain Delivery and Alzheimer's Disease.用于槲皮素脑递送和阿尔茨海默病治疗的RVG29功能化脂质纳米颗粒
Pharm Res. 2020 Jul 13;37(7):139. doi: 10.1007/s11095-020-02865-1.
8
Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.载尼索地平的纳米结构脂质载体和固体脂质纳米粒口服给药的比较研究:制备、表征、渗透和药代动力学评价。
Artif Cells Nanomed Biotechnol. 2018;46(sup2):616-625. doi: 10.1080/21691401.2018.1465068. Epub 2018 Apr 24.
9
Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.蔗糖酯稳定的固体脂质纳米粒和纳米结构脂质载体。I. 制剂变量对克霉唑负载纳米粒的理化性质、药物释放和稳定性的影响。
Nanotechnology. 2014 Mar 14;25(10):105101. doi: 10.1088/0957-4484/25/10/105101. Epub 2014 Feb 14.
10
Formulation, Characterization, and Cytotoxicity Evaluation of Lactoferrin Functionalized Lipid Nanoparticles for Riluzole Delivery to the Brain.用于将利鲁唑递送至脑部的乳铁蛋白功能化脂质纳米粒的制剂、表征及细胞毒性评价
Pharmaceutics. 2022 Jan 13;14(1):185. doi: 10.3390/pharmaceutics14010185.

引用本文的文献

1
Recent Advancements in Lipid Nanoparticles-Based Phytoactives Delivery Systems for Neurodegenerative Diseases.基于脂质纳米颗粒的神经退行性疾病植物活性成分递送系统的最新进展
Int J Nanomedicine. 2025 Aug 25;20:10279-10300. doi: 10.2147/IJN.S537566. eCollection 2025.
2
Crossing the Blood-Brain Barrier: Innovations in Receptor- and Transporter-Mediated Transcytosis Strategies.穿越血脑屏障:受体介导和转运体介导的转胞吞作用策略的创新
Pharmaceutics. 2025 May 28;17(6):706. doi: 10.3390/pharmaceutics17060706.
3
Preparation of Nanoparticle-Immobilized Gold Surfaces for the Reversible Conjugation of Neurotensin Peptide.
用于神经降压素肽可逆共轭的纳米颗粒固定金表面的制备
Biomolecules. 2025 May 27;15(6):767. doi: 10.3390/biom15060767.
4
Breaking barriers: exploring blood-brain barrier crossing mechanisms with nanomedicine for effective glioma treatment.突破障碍:利用纳米医学探索血脑屏障穿越机制以实现有效的胶质瘤治疗。
3 Biotech. 2025 Jul;15(7):213. doi: 10.1007/s13205-025-04378-3. Epub 2025 Jun 13.
5
Advancing Brain Targeting: Cost-Effective Surface-Modified Nanoparticles for Faster Market Entry.推进脑靶向:具有成本效益的表面改性纳米颗粒,以更快进入市场。
Pharmaceutics. 2025 May 17;17(5):661. doi: 10.3390/pharmaceutics17050661.
6
Microfluidic synthesis of stable and uniform curcumin-loaded solid lipid nanoparticles with high encapsulation efficiency.微流控合成具有高包封率的稳定且均匀的载姜黄素固体脂质纳米粒。
RSC Adv. 2025 Apr 4;15(14):10547-10556. doi: 10.1039/d4ra08284b.
7
Pegylated gold nanoparticles interact with lipid bilayer and human serum albumin and transferrin.聚乙二醇化金纳米颗粒与脂质双层以及人血清白蛋白和转铁蛋白相互作用。
Sci Rep. 2024 Oct 18;14(1):24408. doi: 10.1038/s41598-024-74898-0.
8
Brain-on-a-chip: an emerging platform for studying the nanotechnology-biology interface for neurodegenerative disorders.脑芯片:用于研究神经退行性疾病中纳米技术-生物学界面的新兴平台。
J Nanobiotechnology. 2024 Sep 18;22(1):573. doi: 10.1186/s12951-024-02720-0.
9
Nanozyme as a rising star for metabolic disease management.纳米酶:代谢疾病管理的新兴之星。
J Nanobiotechnology. 2024 May 6;22(1):226. doi: 10.1186/s12951-024-02478-5.
10
Rationalized landscape on protein-based cancer nanomedicine: Recent progress and challenges.基于蛋白质的癌症纳米药物的合理设计:最新进展与挑战
Int J Pharm X. 2024 Mar 11;7:100238. doi: 10.1016/j.ijpx.2024.100238. eCollection 2024 Jun.